Earth Science Tech Inc. (OTC: ETST) is strategically positioning itself within the rapidly evolving telehealth and peptide therapy industries, leveraging its proprietary technology and vertically integrated business model to capture market share in sectors projected for substantial growth. The company, a holding company that acquires and manages operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and select consumer markets, is building value through its subsidiaries, including DOConsultations LLC and Las Villas Health Care Inc.
The telehealth market, in which ETST has established a presence through its investments, is projected to reach $251.5 billion by 2030, reflecting a compound annual growth rate (CAGR) of 11.3% between 2025 and 2030 (https://ibn.fm/EiRW6). This growth is driven by increasing demand for remote healthcare services and advancements in digital health technologies. ETST is also capitalizing on the surging demand for peptide therapies, an industry expected to hit $249 billion by 2033. Peptides are gaining traction in medical treatments due to their clinical effectiveness in areas such as metabolic disorders, cancer, and infectious diseases.
ETST's success is built on its proprietary technology and IT infrastructure, which provide a significant competitive edge. By continuously pushing innovative tech development and expanding vertical integration, the company is able to identify unique market opportunities and steadily grow its market share. The company’s understanding of the market allows it to tap into sectors that are projected to grow tremendously over the coming years.
Through its subsidiaries, ETST is positioned to offer a range of services and products that cater to the evolving needs of the healthcare industry. DOConsultations LLC provides telemedicine solutions, while Las Villas Health Care Inc. focuses on healthcare services. These subsidiaries benefit from ETST's centralized resources and strategic direction, enabling them to operate efficiently and scale effectively.
The company's focus on innovation and strategic acquisitions aligns with broader industry trends, where technology-driven healthcare solutions are becoming increasingly important. By leveraging its proprietary technology, ETST aims to differentiate itself from competitors and capture a larger share of the growing telehealth and peptide therapy markets.
For more information on Earth Science Tech Inc., visit the company’s newsroom at https://ibn.fm/ETST. This press release is distributed by InvestorWire, a specialized communications platform within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions, article syndication to 5,000+ outlets, and social media distribution to millions of followers. InvestorWire is based in Austin, Texas, and can be reached at 512.354.7000 Office or Editor@InvestorWire.com. For more details, visit https://www.InvestorWire.com and see full terms of use and disclaimers at https://www.InvestorWire.com/Disclaimer.
